Stockscreener 앱 받기
7.15
13.85%
0.87
시간 외 거래:
7.01
-0.14
-1.96%
전일 마감가:
$6.28
열려 있는:
$6.33
하루 거래량:
2.45M
Relative Volume:
5.11
시가총액:
$131.94M
수익:
$62.81M
순이익/손실:
$-13.75M
주가수익비율:
-8.9375
EPS:
-0.8
순현금흐름:
$153.00K
1주 성능:
+51.48%
1개월 성능:
+13.67%
6개월 성능:
-8.33%
1년 성능:
-47.15%
1일 변동 폭
$6.2018
$7.83
1주일 범위
$3.9914
$7.83
52주 변동 폭
$3.78
$14.13
Optimizerx Corp Stock (OPRX) Company Profile
명칭
Optimizerx Corp
전화
248-651-6558
주소
260 CHARLES STREET, WALTHAM, MI
OPRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
7.15 | 131.94M | 62.81M | -13.75M | 153.00K | -0.80 |
|
VEEV
Veeva Systems Inc
|
227.80 | 36.98B | 2.75B | 714.14M | 1.09B | 4.33 |
|
SOLV
Solventum Corp
|
72.30 | 12.51B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
60.80 | 11.41B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
93.97 | 8.14B | 1.15B | 96.70M | -161.99M | 1.09 |
|
TEM
Tempus Ai Inc
|
42.16 | 7.26B | 640.44M | -743.28M | -206.93M | -11.29 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-08 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-12-20 | 개시 | Stephens | Equal-Weight |
| 2024-07-25 | 재개 | B. Riley Securities | Buy |
| 2024-04-04 | 개시 | JMP Securities | Mkt Outperform |
| 2024-01-03 | 개시 | Barclays | Equal Weight |
| 2023-02-02 | 재개 | B. Riley Securities | Buy |
| 2022-11-01 | 개시 | Stifel | Buy |
| 2022-07-15 | 개시 | SVB Leerink | Outperform |
| 2021-10-18 | 재개 | B. Riley Securities | Buy |
| 2021-04-13 | 개시 | RBC Capital Mkts | Outperform |
| 2019-01-03 | 개시 | William Blair | Outperform |
모두보기
Optimizerx Corp 주식(OPRX)의 최신 뉴스
OptimizeRx Corp [OPRX] CEO makes an insider purchase of 20,000 shares worth 0.1 million. - Knox Daily
OptimizeRx (NASDAQ:OPRX) Issues Quarterly Earnings Results - MarketBeat
OptimizeRx Corporation (NASDAQ:OPRX) Q4 2024 Earnings Call Transcript - Insider Monkey
OptimizeRx Corp (OPRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Margin Expansion - Investing.com Canada
OptimizeRx Clocks Double-Digit Revenue Growth In Q4, Forecasts Sales Of At Least $100 Million - Benzinga
Earnings call transcript: OptimizeRx Q4 2024 sees revenue growth, stock surges By Investing.com - Investing.com South Africa
OPTIMIZERx earnings beat by $0.04, revenue topped estimates - Investing.com
Earnings call transcript: OptimizeRx Q4 2024 sees revenue growth, stock surges - Investing.com UK
OptimizeRx Corp reports results for the quarter ended December 31Earnings Summary - TradingView
OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Beat Estimates - Yahoo Finance
OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results - TradingView
OptimizeRx receives board nomination notice from Whetstone By Investing.com - Investing.com Australia
OptimizeRx Corporation Confirms Receipt of Notice of Director Nominations - The Manila Times
OPTIMIZERx receives director nominations from Whetstone Capital Advisors -March 11, 2025 at 07:42 am EDT - Marketscreener.com
OptimizeRx receives board nomination notice from Whetstone - Investing.com
OptimizeRx Faces Board Shakeup as Activist Investor Pushes for Change - StockTitan
OptimizeRx appoints Steve Silvestro as new CEO By Investing.com - Investing.com Australia
OptimizeRx appoints Steve Silvestro as new CEO - Investing.com India
OptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive Officer - The Manila Times
OPTIMIZERx appoints Stephen Silvestro as CEO -March 10, 2025 at 07:42 am EDT - Marketscreener.com
OptimizeRx Promotes CCO Steve Silvestro to Chief Executive Officer - StockTitan
OptimizeRx (OPRX) to Release Earnings on Wednesday - MarketBeat
OptimizeRx Corp. to Host Earnings Call - ACCESS Newswire
What Does OptimizeRx Corporation's (NASDAQ:OPRX) Share Price Indicate? - Yahoo Finance
Investor Network: OptimizeRx Corp to Host Earnings Call - ACCESS Newswire
OptimizeRx Sets Fourth Quarter and Full Year 2024 Financial Results Conference Call for March 12, 2025, at 8:30 a.m. ET - The Manila Times
OptimizeRx Corp. Announces Conference Call to Discuss Fiscal 2024 Financial Results on March 12, 2025 - Nasdaq
OptimizeRx Sets Fourth Quarter and Full Year 2024 Financial Results Conference Call for March ... - The Bakersfield Californian
OptimizeRx Co. (NASDAQ:OPRX) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Head to Head Review: NextMart (OTCMKTS:NXMR) and OptimizeRx (NASDAQ:OPRX) - Defense World
OptimizeRx's SWOT analysis: digital health stock faces growth hurdles - Investing.com
SG Americas Securities LLC Acquires New Stake in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
Why Insider Buys at OptimizeRx Could Signal Undervalued Potential - Smartphone Magazine
One OptimizeRx Insider Raised Their Stake In The Previous Year - Yahoo Finance
OptimizeRx (NASDAQ:OPRX) Receives "Market Outperform" Rating from JMP Securities - MarketBeat
JPMorgan Chase & Co. Sells 104,750 Shares of OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
Where OptimizeRx Stands With AnalystsOptimizeRx (NASDAQ:OPRX) - Benzinga
Whetstone Capital Discloses 8.2% Stake in OptimizeRx, Urges Strategic Alternatives - Yahoo Finance
OptimizeRx Co. (NASDAQ:OPRX) Receives $9.06 Consensus Target Price from Brokerages - Defense World
Chuck Royce's Strategic Acquisition of OptimizeRx Corp Shares - GuruFocus.com
OptimizeRx Co. (NASDAQ:OPRX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
OptimizeRx (NASDAQ:OPRX) adds US$12m to market cap in the past 7 days, though investors from three years ago are still down 87% - Simply Wall St
Strong week for OptimizeRx (NASDAQ:OPRX) shareholders doesn't alleviate pain of three-year loss - Yahoo Finance
Contrasting Ucommune International (NASDAQ:UK) and OptimizeRx (NASDAQ:OPRX) - Defense World
OptimizeRx Co. (NASDAQ:OPRX) Shares Sold by Jane Street Group LLC - Defense World
OptimizeRx downgraded to "sector perform" by RBC amid slower growth outlook - MSN
Optimizerx Corp (OPRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.27%
자본화:
|
볼륨(24시간):